
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
ERT has surveyed clinical professionals, in April and May 2020, on how the demands of the COVID-19 pandemic were affecting their organizations’ use and planned use of virtual trial technologies. Some findings include the biggest issue keeping participants up at night-screening for new clinical trials patients.
For more of the survey’s findings, click






